MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $73,863,000 | +40.0% | 1,407,438 | -11.3% | 0.02% | +23.1% |
| Q2 2020 | $52,777,000 | +29.4% | 1,586,358 | +5.8% | 0.01% | +8.3% |
| Q1 2020 | $40,794,000 | +54.3% | 1,499,782 | +11.9% | 0.01% | +100.0% |
| Q4 2019 | $26,438,000 | +54.6% | 1,340,011 | +1.6% | 0.01% | +50.0% |
| Q3 2019 | $17,100,000 | +7.7% | 1,319,535 | +3.5% | 0.00% | 0.0% |
| Q2 2019 | $15,879,000 | -13.6% | 1,275,473 | +0.9% | 0.00% | -20.0% |
| Q1 2019 | $18,373,000 | +57.2% | 1,264,461 | +19.4% | 0.01% | +66.7% |
| Q4 2018 | $11,690,000 | -56.1% | 1,058,902 | +4.7% | 0.00% | -57.1% |
| Q3 2018 | $26,603,000 | +31.8% | 1,011,533 | +2.5% | 0.01% | +40.0% |
| Q2 2018 | $20,181,000 | +20.5% | 986,868 | +6.9% | 0.01% | +25.0% |
| Q1 2018 | $16,748,000 | +30.7% | 922,744 | +0.4% | 0.00% | +33.3% |
| Q4 2017 | $12,815,000 | -24.0% | 918,726 | +0.8% | 0.00% | -25.0% |
| Q3 2017 | $16,868,000 | +10.4% | 911,814 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $15,283,000 | +42.0% | 904,238 | +12.1% | 0.00% | +33.3% |
| Q1 2017 | $10,765,000 | -7.7% | 806,345 | +4.0% | 0.00% | -25.0% |
| Q4 2016 | $11,665,000 | +33.0% | 775,056 | +3.3% | 0.00% | +33.3% |
| Q3 2016 | $8,770,000 | +9.7% | 750,233 | +1.4% | 0.00% | 0.0% |
| Q2 2016 | $7,991,000 | +15.8% | 739,941 | -0.9% | 0.00% | +50.0% |
| Q1 2016 | $6,902,000 | -36.9% | 746,944 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $10,946,000 | -7.3% | 737,567 | +2.5% | 0.00% | 0.0% |
| Q3 2015 | $11,803,000 | -20.1% | 719,274 | +11.1% | 0.00% | 0.0% |
| Q2 2015 | $14,763,000 | +67.7% | 647,245 | +11.7% | 0.00% | +33.3% |
| Q1 2015 | $8,804,000 | +26.3% | 579,247 | +0.1% | 0.00% | +50.0% |
| Q4 2014 | $6,969,000 | +4.1% | 578,804 | -2.0% | 0.00% | 0.0% |
| Q3 2014 | $6,695,000 | -6.3% | 590,437 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $7,143,000 | -7.6% | 591,293 | -10.9% | 0.00% | 0.0% |
| Q1 2014 | $7,729,000 | -39.1% | 663,525 | -7.5% | 0.00% | -50.0% |
| Q4 2013 | $12,684,000 | +23.0% | 717,434 | +0.1% | 0.00% | 0.0% |
| Q3 2013 | $10,312,000 | -5.5% | 716,574 | -1.1% | 0.00% | 0.0% |
| Q2 2013 | $10,914,000 | – | 724,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |